Schuurhuis, G. J., Heuser, M., Freeman, S., Bene, M. C., Buccisano, F., Cloos, J., et al. (2018). Minimal/measurable residual disease in AML: A consensus document from the European LeukemiaNet MRD Working Party. Blood, 131(12), 1275–1291. https://doi.org/10.1182/blood-2017-09-801498

Article  CAS  Google Scholar 

Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014). Mechanisms of disseminated cancer cell dormancy: An awakening field. Nature Reviews Cancer, 14(9), 611–622. https://doi.org/10.1038/nrc3793

Article  CAS  Google Scholar 

Alix-Panabieres, C., & Pantel, K. (2021). Liquid biopsy: From discovery to clinical application. Cancer Discovery, 11(4), 858–873. https://doi.org/10.1158/2159-8290.CD-20-1311

Article  CAS  Google Scholar 

MacKie, R. M., Reid, R., & Junor, B. (2003). Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. New England Journal of Medicine, 348(6), 567–568. https://doi.org/10.1056/NEJM200302063480620

Article  Google Scholar 

Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., et al. (2007). Adaptive immunity maintains occult cancer in an equilibrium state. Nature, 450(7171), 903–907. https://doi.org/10.1038/nature06309

Article  CAS  Google Scholar 

Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002). Cancer immunoediting: From immunosurveillance to tumor escape. Nature Immunology, 3(11), 991–998. https://doi.org/10.1038/ni1102-991

Article  CAS  Google Scholar 

Eyles, J., Puaux, A. L., Wang, X., Toh, B., Prakash, C., Hong, M., et al. (2010). Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. The Journal of Clinical Investigation, 120(6), 2030–2039. https://doi.org/10.1172/JCI42002

Article  CAS  Google Scholar 

Husemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., et al. (2008). Systemic spread is an early step in breast cancer. Cancer Cell, 13(1), 58–68. https://doi.org/10.1016/j.ccr.2007.12.003

Article  CAS  Google Scholar 

Hosseini, H., Obradovic, M. M. S., Hoffmann, M., Harper, K. L., Sosa, M. S., Werner-Klein, M., et al. (2016). Early dissemination seeds metastasis in breast cancer. Nature, 540(7634), 552–558. https://doi.org/10.1038/nature20785

Article  CAS  Google Scholar 

Hu, Z., Ding, J., Ma, Z., Sun, R., Seoane, J. A., Scott Shaffer, J., et al. (2019). Quantitative evidence for early metastatic seeding in colorectal cancer. Nature Genetics, 51(7), 1113–1122. https://doi.org/10.1038/s41588-019-0423-x

Article  CAS  Google Scholar 

De Angelis, M. L., Francescangeli, F., & Zeuner, A. (2019). Breast cancer stem cells as drivers of tumor chemoresistance, dormancy and relapse: new challenges and therapeutic opportunities. Cancers (Basel), 11(10), 1569. https://doi.org/10.3390/cancers11101569

Article  CAS  Google Scholar 

Pantel, K., & Alix-Panabieres, C. (2010). Circulating tumour cells in cancer patients: Challenges and perspectives. Trends in Molecular Medicine, 16(9), 398–406. https://doi.org/10.1016/j.molmed.2010.07.001

Article  Google Scholar 

Chaffer, C. L., & Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science, 331(6024), 1559–1564. https://doi.org/10.1126/science.1203543

Article  CAS  Google Scholar 

Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., et al. (2017). Role of tumor microenvironment in tumorigenesis. Journal of Cancer, 8(5), 761–773. https://doi.org/10.7150/jca.17648

Article  CAS  Google Scholar 

Joosse, S. A., Gorges, T. M., & Pantel, K. (2015). Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med, 7(1), 1–11. https://doi.org/10.15252/emmm.201303698

Article  CAS  Google Scholar 

Werner, S., Heidrich, I., & Pantel, K. (2022). Clinical management and biology of tumor dormancy in breast cancer. Seminars in Cancer Biology, 78, 49–62. https://doi.org/10.1016/j.semcancer.2021.02.001

Article  CAS  Google Scholar 

Park, S. Y., & Nam, J. S. (2020). The force awakens: Metastatic dormant cancer cells. Experimental & Molecular Medicine, 52(4), 569–581. https://doi.org/10.1038/s12276-020-0423-z

Article  CAS  Google Scholar 

Blatter, S., & Rottenberg, S. (2015). Minimal residual disease in cancer therapy–small things make all the difference. Drug Resist Updat, 21–22, 1–10. https://doi.org/10.1016/j.drup.2015.08.003

Article  Google Scholar 

Aguirre-Ghiso, J. A. (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nature Reviews Cancer, 7(11), 834–846. https://doi.org/10.1038/nrc2256

Article  CAS  Google Scholar 

Saleh, T., Tyutyunyk-Massey, L., & Gewirtz, D. A. (2019). Tumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy. Cancer Research, 79(6), 1044–1046. https://doi.org/10.1158/0008-5472.CAN-18-3437

Article  CAS  Google Scholar 

Coppe, J. P., Desprez, P. Y., Krtolica, A., & Campisi, J. (2010). The senescence-associated secretory phenotype: The dark side of tumor suppression. Annual Review of Pathology: Mechanisms of Disease, 5, 99–118. https://doi.org/10.1146/annurev-pathol-121808-102144

Article  CAS  Google Scholar 

Dhimolea, E., de Matos Simoes, R., Kansara, D., Al’Khafaji, A., Bouyssou, J., Weng, X., et al. (2021). An embryonic diapause-like adaptation with suppressed Myc activity enables tumor treatment persistence. Cancer Cell, 39(2), 240-256e211. https://doi.org/10.1016/j.ccell.2020.12.002

Article  CAS  Google Scholar 

Rehman, S. K., Haynes, J., Collignon, E., Brown, K. R., Wang, Y., Nixon, A. M. L., et al. (2021). Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy. Cell, 184(1), 226-242 e221. https://doi.org/10.1016/j.cell.2020.11.018

Article  CAS  Google Scholar 

Greil, R., Hutterer, E., Hartmann, T. N., & Pleyer, L. (2017). Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation. Cell Communication and Signaling: CCS, 15(1), 5. https://doi.org/10.1186/s12964-016-0155-9

Article  CAS  Google Scholar 

Raha, D., Wilson, T. R., Peng, J., Peterson, D., Yue, P., Evangelista, M., et al. (2014). The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer Research, 74(13), 3579–3590. https://doi.org/10.1158/0008-5472.CAN-13-3456

Article  CAS  Google Scholar 

Nobre, A. R., Entenberg, D., Wang, Y., Condeelis, J., & Aguirre-Ghiso, J. A. (2018). The different routes to metastasis via hypoxia-regulated programs. Trends in Cell Biology, 28(11), 941–956. https://doi.org/10.1016/j.tcb.2018.06.008

Article  CAS  Google Scholar 

Fluegen, G., Avivar-Valderas, A., Wang, Y., Padgen, M. R., Williams, J. K., Nobre, A. R., et al. (2017). Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nature Cell Biology, 19(2), 120–132. https://doi.org/10.1038/ncb3465

Article  CAS  Google Scholar 

Yu, M., Bardia, A., Aceto, N., Bersani, F., Madden, M. W., Donaldson, M. C., et al. (2014). Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science, 345(6193), 216–220. https://doi.org/10.1126/science.1253533

Article  CAS  Google Scholar 

Cheng, Y. H., Chen, Y. C., Lin, E., Brien, R., Jung, S., Chen, Y. T., et al. (2019). Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells. Nature Communications, 10(1), 2163. https://doi.org/10.1038/s41467-019-10122-2

Article  CAS  Google Scholar 

Gkountela, S., Castro-Giner, F., Szczerba, B. M., Vetter, M., Landin, J., Scherrer, R., et al. (2019). Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell, 176(1–2), 98-112 e114. https://doi.org/10.1016/j.cell.2018.11.046

Article  CAS  Google Scholar 

Kwan, T. T., Bardia, A., Spring, L. M., Giobbie-Hurder, A., Kalinich, M., Dubash, T., et al. (2018). A digital RNA signature of circulating tumor cells predicting early therapeutic response in localized and metastatic breast cancer. Cancer Discovery, 8(10), 1286–1299. https://doi.org/10.1158/2159-8290.CD-18-0432

Article  CAS  Google Scholar 

Pantel, K., & Alix-Panabieres, C. (2019). Liquid biopsy and minimal residual disease - latest advances and implications for cure. Nature Reviews. Clinical Oncology, 16(7), 409–424. https://doi.org/10.1038/s41571-019-0187-3

Article  CAS  Google Scholar 

Keller, L., & Pantel, K. (2019). Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells. Nature Reviews Cancer, 19(10), 553–567. https://doi.org/10.1038/s41568-019-0180-2

Article  CAS  Google Scholar 

Braun, S., Vogl, F. D., Naume, B., Janni, W., Osborne, M. P., Coombes, R. C., et al. (2005). A pooled analysis of bone marrow micrometastasis in breast cancer. New England Journal of Medicine, 353(8), 793–802. https://doi.org/10.1056/NEJMoa050434

Article  CAS  Google Scholar 

Soler, A., Cayrefourcq, L., Mazel, M., & Alix-Panabieres, C. (2017). EpCAM-independent enrichment and detection of viable circulating tumor cells using the EPISPOT assay. Methods in Molecular Biology, 1634, 263–276. https://doi.org/10.1007/978-1-4939-7144-2_22

Article  CAS  Google Scholar 

Koch, C., Kuske, A., Joosse, S. A., Yigit, G., Sflomos, G., Thaler, S., et al. (2020). Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. EMBO Mol Med, 12(9), e11908. https://doi.org/10.15252/emmm.201911908

Article  CAS  Google Scholar 

Bardelli, A., & Pantel, K. (2017). Liquid Biopsies, what we do not know (yet). Cancer Cell, 31(2), 172–179. https://doi.org/10.1016/j.ccell.2017.01.002

Article  CAS  Google Scholar 

Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016). Origins, structures, and functions of circulating DNA in oncology. Cancer and Metastasis Reviews, 35(3), 347–376. https://doi.org/10.1007/s10555-016-9629-x

Article  CAS  Google Scholar 

Elazezy, M., & Joosse, S. A. (2018). Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management. Computational and Structural Biotechnology Journal, 16, 370–378. https://doi.org/10.1016/j.csbj.2018.10.002

Article  CAS  Google Scholar 

Vendrell, J. A., Mau-Them, F. T., Beganton, B., Godreuil, S., Coopman, P., & Solassol, J. (2017). Circulating cell free tumor DNA detection as a routine tool for lung cancer patient management. International Journal of Molecular Sciences, 18(2), 264. https://doi.org/10.3390/ijms18020264

Article  CAS